SlideShare a Scribd company logo
STATISTICAL EPIDEMIOLOGY
Epidemiology study of disease condition in population
Epidemiology is the science that studies the patterns ,causes,and effects of health and disease
conditions in defined the populations.it is the cornerstone of public health and informs policy
decisions and evidence-based practice by identifying risk factors for disease and targets for
preventive healthcare.
Fertility rate- study related to the birth
Mortality rate – study related to the death
Morbidity rate- study related to the disease condition.
OBJECTIVES OF EPIDEMIOLOGY
 To determine the rates of disease by person, place and time - Absolute risk ( incidence,
prevalence)
 To identify the risk factors for the disease - Relative risk (or odds ratio)
 To develop approaches for disease prevention - Attributable risk / fraction
MEASUREMENTS IN EPIDEMIOLOGY
 Epidemiology is about identifying associations between exposures and outcomes.
 To identify any association, exposures and outcomes must first be measured in a
quantitative manner.
 “measures of disease frequency.”
 “measures of association or effect.”
 “measures of potential impact.”
MORBIDITYRATE:
The health workers are interested in assessing the health status of the
communities through morbidity.morbidity relates to types and varieties of
diseasesone faces orexperiences affecting the day-to –day activities.data for
the study of morbidity of a community are available from registration
through hospitals
INCIDENCE RATE:
Incidence rate relates to the total number of new casesofspecific disease in
during year with mid year population.
 Incidence is defined as a number of new cases of a disease occurring in a specified time
period divided by the number of individuals at risk of developing the disease during the
same time
 Incidence is most relevant clinically
Total number of new cases of a specific disease during year
Incidence rate = × K
Mid year population
K is constant value,
The value of k may be taken as 100,10000 or 100000.base the numerator value we choose the
value of K
Example:
- 10,000 people without heart disease
- Follow population for 5 years
- 3,000 people smoke
- 410 of smokers develop heart disease
- 350 of non-smokers develop heart disease
- No loss to follow-up or change in smoking status over time
PREVALENCE
Prevalence rate relatedto the total number of cases,(i,e)new orold excisting
at a point of time with totalpopulation.
o Prevalence is defines as a total number of affected individuals in a population at a
specified time period divided by the number of individuals in the population at the
time
Total number of cases,newor
old existing at a point of time
Prevalence = ––––––––––––––––––––––––––––––– × K
total Population at a point of time
o That is, prevalence is equal to the probability of disease:
Mid year prevalence:
Arithmetic mean of the population on 1 jan and the population on 31 december of a
year.it is used to calculate annual rates.
TYPES OF PREVALENCE
1.POINT PREVALENCE
 It is relates to prevalence with respect to a specific point in time.
 Point prevalence is the proportion of a population that has the condition at a specific
point in time.
 Eg . Did you have an asthma attack on Monday?
2.PERIOD PREVALENCE
 Related to prevalence over a defined period of time.
 Period prevalence is the proportion of a population that has the condition at some time
during a given period (e.g., 12 month prevalence), and includes people who already have
the condition at the start of the study period as well as those who acquire it during that
period.
 Eg . Did you have an asthma attack in january?
3.LIFE TIME PREVALENCE
 Lifetime prevalence (LTP) is the proportion of a population that at some point in their
life (up to the time of assessment) have experienced the condition
 Eg . Have you ever had an asthma attack
RELATIVE RISK OR RISK RATIO (RR)
In statistics and epidemiology, relative risk or risk ratio (RR) is the ratio of the probability of an
event occurring (for example, developing a disease, being injured) in an exposed group to the
probability of the event occurring in a comparison, non-exposed group.
 Categorical data in medical/health/nutrition investigations are frequently used to calculate
the risk of disease who are exposed to a specific character and not exposed to a specific
character.the basic requirement of this syudy is 2 × 2 table giving number of diseased
cases in those exposed and in those unexposed.
 Consider the first group as exposed and second group as exposed and second group as
unexposed.if n11 & n 12 get the disease in the respective groups.
Risk of the disease in the exposed group = n11 / n 1
risk of the disease in the unexpected group = n12 / n2
n11 / n 1
relative risk =
n12 / n 2
Relative Risk interpretation
 Ratios > 1.0 indicate rate is higher among exposed than unexposed (indicates positive
association)
 Ratios = 1.0 indicate no association
Ratios < 1.0 indicate rate is lower among exposed than unexposed( indicates negative
association)
ATTRIBUTABLE RISK (AR)
 In epidemiology ,the attributable risk is the difference in the rate of condition between the
risk in exposed subjects and unexposed subjects is called attributable risk
 This can also be understood as risk difference.
 Attributable risk is mostly calculated in cohort studies,where individuals are assembled
on exposure status and followed over a period of time.
 Attributable risk gives more valid information to the health managers than the relative
risk. This happens particularly when the disease is rare but occurs several times more
frequently if a particular antecedent is present.
 Attributable risk is better index of the public health importance of the risk factor in terms
of the impact its reduction can make on the overall incidence of disease.
 Calculation of AR = risk(incidence) in exposed – risk(incidence) in non-
exposedwhich provides the risk difference
ATTRIBUTABLE FRACTION (AF)
 AF is the proportion of disease incidence that can be attributed to a specific exposure
(among those who were exposed)
 AR divided by incidence in the exposed X 100%

More Related Content

What's hot

Determination of dose and dosing interval
Determination of dose and dosing intervalDetermination of dose and dosing interval
Determination of dose and dosing interval
Dr. Ramesh Bhandari
 
Drug Utilization review
Drug Utilization review Drug Utilization review
Drug Utilization review
Pooja Panjwani
 
Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens
pavithra vinayak
 
Adaptive method OR dosing with feedback
Adaptive method OR dosing with feedbackAdaptive method OR dosing with feedback
Adaptive method OR dosing with feedback
pavithra vinayak
 
Population pharmacokinetics
Population pharmacokineticsPopulation pharmacokinetics
Population pharmacokinetics
Dr. Ramesh Bhandari
 
Pharmacy Practice: Managing Formularies
Pharmacy Practice: Managing FormulariesPharmacy Practice: Managing Formularies
Pharmacy Practice: Managing Formularies
Anas Bahnassi أنس البهنسي
 
Design of Dosage form
Design of Dosage formDesign of Dosage form
Design of Dosage form
Dr. Ramesh Bhandari
 
Analysis of pk data- Pop PK analysis
Analysis of pk data- Pop PK analysisAnalysis of pk data- Pop PK analysis
Analysis of pk data- Pop PK analysisGayathri Ravi
 
DESIGN OF DOSAGE REGIMEN.pptx
DESIGN OF DOSAGE REGIMEN.pptxDESIGN OF DOSAGE REGIMEN.pptx
DESIGN OF DOSAGE REGIMEN.pptx
DrAniqaSundas
 
Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology
ABUBAKRANSARI2
 
Pharmacokinetic changes of drugs in hepatic diseases
Pharmacokinetic changes of drugs in hepatic diseasesPharmacokinetic changes of drugs in hepatic diseases
Pharmacokinetic changes of drugs in hepatic diseases
Dr Htet
 
Hospital Pharmaco-epidemiology
Hospital Pharmaco-epidemiology Hospital Pharmaco-epidemiology
Hospital Pharmaco-epidemiology
Dr. Ashish singh parihar
 
Individualization of dosage regimen
Individualization of dosage regimenIndividualization of dosage regimen
Individualization of dosage regimen
PARUL UNIVERSITY
 
Prescription event monitoring and record linkage system
Prescription event monitoring and record linkage systemPrescription event monitoring and record linkage system
Prescription event monitoring and record linkage systemVineetha Menon
 
Developing therapeutic guidelines
Developing therapeutic guidelines  Developing therapeutic guidelines
Developing therapeutic guidelines
Irene Vadakkan
 
Dose adjustment in Renal Disorders
Dose adjustment in Renal DisordersDose adjustment in Renal Disorders
Dose adjustment in Renal Disorders
Dr. Ramesh Bhandari
 
Dose in uremia
Dose in uremiaDose in uremia
Dose in uremia
Gayathri Kannanunny
 
Effects of liver diseases on pharmacokinetics
Effects of liver diseases on pharmacokineticsEffects of liver diseases on pharmacokinetics
Effects of liver diseases on pharmacokinetics
Dr. Ramesh Bhandari
 
Drug utilization evaluation
Drug utilization evaluationDrug utilization evaluation
Drug utilization evaluation
Dr. Ramesh Bhandari
 
Clinical pharmacokinetics and its application
Clinical pharmacokinetics and its applicationClinical pharmacokinetics and its application
Clinical pharmacokinetics and its application
pavithra vinayak
 

What's hot (20)

Determination of dose and dosing interval
Determination of dose and dosing intervalDetermination of dose and dosing interval
Determination of dose and dosing interval
 
Drug Utilization review
Drug Utilization review Drug Utilization review
Drug Utilization review
 
Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens
 
Adaptive method OR dosing with feedback
Adaptive method OR dosing with feedbackAdaptive method OR dosing with feedback
Adaptive method OR dosing with feedback
 
Population pharmacokinetics
Population pharmacokineticsPopulation pharmacokinetics
Population pharmacokinetics
 
Pharmacy Practice: Managing Formularies
Pharmacy Practice: Managing FormulariesPharmacy Practice: Managing Formularies
Pharmacy Practice: Managing Formularies
 
Design of Dosage form
Design of Dosage formDesign of Dosage form
Design of Dosage form
 
Analysis of pk data- Pop PK analysis
Analysis of pk data- Pop PK analysisAnalysis of pk data- Pop PK analysis
Analysis of pk data- Pop PK analysis
 
DESIGN OF DOSAGE REGIMEN.pptx
DESIGN OF DOSAGE REGIMEN.pptxDESIGN OF DOSAGE REGIMEN.pptx
DESIGN OF DOSAGE REGIMEN.pptx
 
Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology
 
Pharmacokinetic changes of drugs in hepatic diseases
Pharmacokinetic changes of drugs in hepatic diseasesPharmacokinetic changes of drugs in hepatic diseases
Pharmacokinetic changes of drugs in hepatic diseases
 
Hospital Pharmaco-epidemiology
Hospital Pharmaco-epidemiology Hospital Pharmaco-epidemiology
Hospital Pharmaco-epidemiology
 
Individualization of dosage regimen
Individualization of dosage regimenIndividualization of dosage regimen
Individualization of dosage regimen
 
Prescription event monitoring and record linkage system
Prescription event monitoring and record linkage systemPrescription event monitoring and record linkage system
Prescription event monitoring and record linkage system
 
Developing therapeutic guidelines
Developing therapeutic guidelines  Developing therapeutic guidelines
Developing therapeutic guidelines
 
Dose adjustment in Renal Disorders
Dose adjustment in Renal DisordersDose adjustment in Renal Disorders
Dose adjustment in Renal Disorders
 
Dose in uremia
Dose in uremiaDose in uremia
Dose in uremia
 
Effects of liver diseases on pharmacokinetics
Effects of liver diseases on pharmacokineticsEffects of liver diseases on pharmacokinetics
Effects of liver diseases on pharmacokinetics
 
Drug utilization evaluation
Drug utilization evaluationDrug utilization evaluation
Drug utilization evaluation
 
Clinical pharmacokinetics and its application
Clinical pharmacokinetics and its applicationClinical pharmacokinetics and its application
Clinical pharmacokinetics and its application
 

Viewers also liked

Human immunodeficiency virus
Human immunodeficiency virusHuman immunodeficiency virus
Human immunodeficiency virus
Nandhini Sekar
 
Capsules
Capsules Capsules
Capsules
Nandhini Sekar
 
anxiety disorder
anxiety disorder anxiety disorder
anxiety disorder
Nandhini Sekar
 
synthetic fibre and mineral fibre in pharmacognosy
synthetic fibre and mineral fibre in pharmacognosysynthetic fibre and mineral fibre in pharmacognosy
synthetic fibre and mineral fibre in pharmacognosy
Nandhini Sekar
 
Flunarazine
Flunarazine Flunarazine
Flunarazine
Nandhini Sekar
 
Radiation poisoning
Radiation poisoningRadiation poisoning
Radiation poisoning
Nandhini Sekar
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
Divjyot Kaur
 
Clinical pharmacy services
Clinical pharmacy servicesClinical pharmacy services
Clinical pharmacy services
velspharmd
 
clinical pharmacy
clinical pharmacyclinical pharmacy
clinical pharmacy
Sohan Patel
 
Drug & substance abuse Marijuana, Cocaine, Heroine, alcohol and prescription...
Drug  & substance abuse Marijuana, Cocaine, Heroine, alcohol and prescription...Drug  & substance abuse Marijuana, Cocaine, Heroine, alcohol and prescription...
Drug & substance abuse Marijuana, Cocaine, Heroine, alcohol and prescription...
OrnellaRN
 
Clinical pharmacy
Clinical pharmacyClinical pharmacy
Clinical pharmacy
Sitaram Khadka
 
Intro to clinical pharmacy
Intro to clinical pharmacyIntro to clinical pharmacy
Intro to clinical pharmacy
Saeed Akkad
 

Viewers also liked (13)

Human immunodeficiency virus
Human immunodeficiency virusHuman immunodeficiency virus
Human immunodeficiency virus
 
Capsules
Capsules Capsules
Capsules
 
anxiety disorder
anxiety disorder anxiety disorder
anxiety disorder
 
synthetic fibre and mineral fibre in pharmacognosy
synthetic fibre and mineral fibre in pharmacognosysynthetic fibre and mineral fibre in pharmacognosy
synthetic fibre and mineral fibre in pharmacognosy
 
Flunarazine
Flunarazine Flunarazine
Flunarazine
 
Radiation poisoning
Radiation poisoningRadiation poisoning
Radiation poisoning
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 
Substance abuse
Substance abuseSubstance abuse
Substance abuse
 
Clinical pharmacy services
Clinical pharmacy servicesClinical pharmacy services
Clinical pharmacy services
 
clinical pharmacy
clinical pharmacyclinical pharmacy
clinical pharmacy
 
Drug & substance abuse Marijuana, Cocaine, Heroine, alcohol and prescription...
Drug  & substance abuse Marijuana, Cocaine, Heroine, alcohol and prescription...Drug  & substance abuse Marijuana, Cocaine, Heroine, alcohol and prescription...
Drug & substance abuse Marijuana, Cocaine, Heroine, alcohol and prescription...
 
Clinical pharmacy
Clinical pharmacyClinical pharmacy
Clinical pharmacy
 
Intro to clinical pharmacy
Intro to clinical pharmacyIntro to clinical pharmacy
Intro to clinical pharmacy
 

Similar to Statistical epidemiology

Topic 2 MEASURES OF DISEASE FREQUENCY.pptx
Topic 2 MEASURES OF DISEASE FREQUENCY.pptxTopic 2 MEASURES OF DISEASE FREQUENCY.pptx
Topic 2 MEASURES OF DISEASE FREQUENCY.pptx
kihembopamelah
 
Statistical methods in epidemiology.ppt
Statistical methods in epidemiology.pptStatistical methods in epidemiology.ppt
Statistical methods in epidemiology.ppt
Ravinandan A P
 
Epidemiological concepts english
Epidemiological concepts   englishEpidemiological concepts   english
Epidemiological concepts english
MY STUDENT SUPPORT SYSTEM .
 
Introduction to epidemiology
Introduction to epidemiologyIntroduction to epidemiology
Introduction to epidemiologymlogaraj
 
EPIDEMIOLOGY -DETAILED
EPIDEMIOLOGY -DETAILEDEPIDEMIOLOGY -DETAILED
EPIDEMIOLOGY -DETAILED
MAHESWARI JAIKUMAR
 
EPIDEMIOLOGY DETAILED
EPIDEMIOLOGY DETAILEDEPIDEMIOLOGY DETAILED
EPIDEMIOLOGY DETAILED
MAHESWARI JAIKUMAR
 
Introduction to Epidemiology (Year 2 A &B).pptx
Introduction to Epidemiology (Year 2 A &B).pptxIntroduction to Epidemiology (Year 2 A &B).pptx
Introduction to Epidemiology (Year 2 A &B).pptx
abdulrahmanbelewa96
 
Concept f risk
Concept f riskConcept f risk
Concept f risk
yuva sri sai anumula
 
MEASURES OF MORBIDITY.pptx
MEASURES OF MORBIDITY.pptxMEASURES OF MORBIDITY.pptx
MEASURES OF MORBIDITY.pptx
Emmanuel Ali Adamu
 
Fundamentals and Study Design of Epidemiology
Fundamentals and Study Design of EpidemiologyFundamentals and Study Design of Epidemiology
Fundamentals and Study Design of Epidemiology
FarazaJaved
 
NURSING SPECIALIZATION EPIDEMIOLOGY set Z.pptx
NURSING SPECIALIZATION EPIDEMIOLOGY set Z.pptxNURSING SPECIALIZATION EPIDEMIOLOGY set Z.pptx
NURSING SPECIALIZATION EPIDEMIOLOGY set Z.pptx
FREDRICK CIIRA
 
Modern epidemiology
Modern epidemiologyModern epidemiology
Modern epidemiologyUE
 
S2 Basics of Epidemiology.pptx
S2 Basics of Epidemiology.pptxS2 Basics of Epidemiology.pptx
S2 Basics of Epidemiology.pptx
MunnajiMavatkar
 
epidemiology with part 2 (complete) 2.ppt
epidemiology with part 2 (complete)   2.pptepidemiology with part 2 (complete)   2.ppt
epidemiology with part 2 (complete) 2.ppt
AmosWafula3
 
Measures Of Morbidity
Measures Of MorbidityMeasures Of Morbidity
Measures Of Morbidity
Ravi Prakash Verma
 
Epidemiology of periodontal disease
Epidemiology of periodontal diseaseEpidemiology of periodontal disease
Epidemiology of periodontal disease
DR. OINAM MONICA DEVI
 
Epidemiology of periodontal diseases
Epidemiology of periodontal diseasesEpidemiology of periodontal diseases
Epidemiology of periodontal diseases
Navneet Randhawa
 
Epidemiological Mehods [Autosaved].pptx
Epidemiological Mehods [Autosaved].pptxEpidemiological Mehods [Autosaved].pptx
Epidemiological Mehods [Autosaved].pptx
HinaBarkaat
 
Infection and Disease 2021-22.pptx
Infection and Disease 2021-22.pptxInfection and Disease 2021-22.pptx
Infection and Disease 2021-22.pptx
jelikov
 

Similar to Statistical epidemiology (20)

Topic 2 MEASURES OF DISEASE FREQUENCY.pptx
Topic 2 MEASURES OF DISEASE FREQUENCY.pptxTopic 2 MEASURES OF DISEASE FREQUENCY.pptx
Topic 2 MEASURES OF DISEASE FREQUENCY.pptx
 
Statistical methods in epidemiology.ppt
Statistical methods in epidemiology.pptStatistical methods in epidemiology.ppt
Statistical methods in epidemiology.ppt
 
Epidemiology Depuk sir_ 1,2,3 chapter,OK
Epidemiology Depuk sir_ 1,2,3 chapter,OKEpidemiology Depuk sir_ 1,2,3 chapter,OK
Epidemiology Depuk sir_ 1,2,3 chapter,OK
 
Epidemiological concepts english
Epidemiological concepts   englishEpidemiological concepts   english
Epidemiological concepts english
 
Introduction to epidemiology
Introduction to epidemiologyIntroduction to epidemiology
Introduction to epidemiology
 
EPIDEMIOLOGY -DETAILED
EPIDEMIOLOGY -DETAILEDEPIDEMIOLOGY -DETAILED
EPIDEMIOLOGY -DETAILED
 
EPIDEMIOLOGY DETAILED
EPIDEMIOLOGY DETAILEDEPIDEMIOLOGY DETAILED
EPIDEMIOLOGY DETAILED
 
Introduction to Epidemiology (Year 2 A &B).pptx
Introduction to Epidemiology (Year 2 A &B).pptxIntroduction to Epidemiology (Year 2 A &B).pptx
Introduction to Epidemiology (Year 2 A &B).pptx
 
Concept f risk
Concept f riskConcept f risk
Concept f risk
 
MEASURES OF MORBIDITY.pptx
MEASURES OF MORBIDITY.pptxMEASURES OF MORBIDITY.pptx
MEASURES OF MORBIDITY.pptx
 
Fundamentals and Study Design of Epidemiology
Fundamentals and Study Design of EpidemiologyFundamentals and Study Design of Epidemiology
Fundamentals and Study Design of Epidemiology
 
NURSING SPECIALIZATION EPIDEMIOLOGY set Z.pptx
NURSING SPECIALIZATION EPIDEMIOLOGY set Z.pptxNURSING SPECIALIZATION EPIDEMIOLOGY set Z.pptx
NURSING SPECIALIZATION EPIDEMIOLOGY set Z.pptx
 
Modern epidemiology
Modern epidemiologyModern epidemiology
Modern epidemiology
 
S2 Basics of Epidemiology.pptx
S2 Basics of Epidemiology.pptxS2 Basics of Epidemiology.pptx
S2 Basics of Epidemiology.pptx
 
epidemiology with part 2 (complete) 2.ppt
epidemiology with part 2 (complete)   2.pptepidemiology with part 2 (complete)   2.ppt
epidemiology with part 2 (complete) 2.ppt
 
Measures Of Morbidity
Measures Of MorbidityMeasures Of Morbidity
Measures Of Morbidity
 
Epidemiology of periodontal disease
Epidemiology of periodontal diseaseEpidemiology of periodontal disease
Epidemiology of periodontal disease
 
Epidemiology of periodontal diseases
Epidemiology of periodontal diseasesEpidemiology of periodontal diseases
Epidemiology of periodontal diseases
 
Epidemiological Mehods [Autosaved].pptx
Epidemiological Mehods [Autosaved].pptxEpidemiological Mehods [Autosaved].pptx
Epidemiological Mehods [Autosaved].pptx
 
Infection and Disease 2021-22.pptx
Infection and Disease 2021-22.pptxInfection and Disease 2021-22.pptx
Infection and Disease 2021-22.pptx
 

Recently uploaded

Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
Celine George
 
PART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePART A. Introduction to Costumer Service
PART A. Introduction to Costumer Service
PedroFerreira53928
 
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdfESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
Fundacja Rozwoju Społeczeństwa Przedsiębiorczego
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Introduction to Quality Improvement Essentials
Introduction to Quality Improvement EssentialsIntroduction to Quality Improvement Essentials
Introduction to Quality Improvement Essentials
Excellence Foundation for South Sudan
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
GeoBlogs
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
The Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve ThomasonThe Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve Thomason
Steve Thomason
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
bennyroshan06
 

Recently uploaded (20)

Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
 
PART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePART A. Introduction to Costumer Service
PART A. Introduction to Costumer Service
 
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdfESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Introduction to Quality Improvement Essentials
Introduction to Quality Improvement EssentialsIntroduction to Quality Improvement Essentials
Introduction to Quality Improvement Essentials
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
The Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve ThomasonThe Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve Thomason
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
 

Statistical epidemiology

  • 1. STATISTICAL EPIDEMIOLOGY Epidemiology study of disease condition in population Epidemiology is the science that studies the patterns ,causes,and effects of health and disease conditions in defined the populations.it is the cornerstone of public health and informs policy decisions and evidence-based practice by identifying risk factors for disease and targets for preventive healthcare. Fertility rate- study related to the birth Mortality rate – study related to the death Morbidity rate- study related to the disease condition. OBJECTIVES OF EPIDEMIOLOGY  To determine the rates of disease by person, place and time - Absolute risk ( incidence, prevalence)  To identify the risk factors for the disease - Relative risk (or odds ratio)  To develop approaches for disease prevention - Attributable risk / fraction MEASUREMENTS IN EPIDEMIOLOGY  Epidemiology is about identifying associations between exposures and outcomes.  To identify any association, exposures and outcomes must first be measured in a quantitative manner.  “measures of disease frequency.”  “measures of association or effect.”  “measures of potential impact.”
  • 2. MORBIDITYRATE: The health workers are interested in assessing the health status of the communities through morbidity.morbidity relates to types and varieties of diseasesone faces orexperiences affecting the day-to –day activities.data for the study of morbidity of a community are available from registration through hospitals INCIDENCE RATE: Incidence rate relates to the total number of new casesofspecific disease in during year with mid year population.  Incidence is defined as a number of new cases of a disease occurring in a specified time period divided by the number of individuals at risk of developing the disease during the same time  Incidence is most relevant clinically Total number of new cases of a specific disease during year Incidence rate = × K Mid year population K is constant value, The value of k may be taken as 100,10000 or 100000.base the numerator value we choose the value of K Example: - 10,000 people without heart disease - Follow population for 5 years - 3,000 people smoke - 410 of smokers develop heart disease - 350 of non-smokers develop heart disease
  • 3. - No loss to follow-up or change in smoking status over time PREVALENCE Prevalence rate relatedto the total number of cases,(i,e)new orold excisting at a point of time with totalpopulation. o Prevalence is defines as a total number of affected individuals in a population at a specified time period divided by the number of individuals in the population at the time Total number of cases,newor old existing at a point of time Prevalence = ––––––––––––––––––––––––––––––– × K total Population at a point of time o That is, prevalence is equal to the probability of disease: Mid year prevalence: Arithmetic mean of the population on 1 jan and the population on 31 december of a year.it is used to calculate annual rates. TYPES OF PREVALENCE 1.POINT PREVALENCE  It is relates to prevalence with respect to a specific point in time.  Point prevalence is the proportion of a population that has the condition at a specific point in time.  Eg . Did you have an asthma attack on Monday?
  • 4. 2.PERIOD PREVALENCE  Related to prevalence over a defined period of time.  Period prevalence is the proportion of a population that has the condition at some time during a given period (e.g., 12 month prevalence), and includes people who already have the condition at the start of the study period as well as those who acquire it during that period.  Eg . Did you have an asthma attack in january? 3.LIFE TIME PREVALENCE  Lifetime prevalence (LTP) is the proportion of a population that at some point in their life (up to the time of assessment) have experienced the condition  Eg . Have you ever had an asthma attack RELATIVE RISK OR RISK RATIO (RR) In statistics and epidemiology, relative risk or risk ratio (RR) is the ratio of the probability of an event occurring (for example, developing a disease, being injured) in an exposed group to the probability of the event occurring in a comparison, non-exposed group.  Categorical data in medical/health/nutrition investigations are frequently used to calculate the risk of disease who are exposed to a specific character and not exposed to a specific character.the basic requirement of this syudy is 2 × 2 table giving number of diseased cases in those exposed and in those unexposed.  Consider the first group as exposed and second group as exposed and second group as unexposed.if n11 & n 12 get the disease in the respective groups. Risk of the disease in the exposed group = n11 / n 1 risk of the disease in the unexpected group = n12 / n2
  • 5. n11 / n 1 relative risk = n12 / n 2 Relative Risk interpretation  Ratios > 1.0 indicate rate is higher among exposed than unexposed (indicates positive association)  Ratios = 1.0 indicate no association Ratios < 1.0 indicate rate is lower among exposed than unexposed( indicates negative association) ATTRIBUTABLE RISK (AR)  In epidemiology ,the attributable risk is the difference in the rate of condition between the risk in exposed subjects and unexposed subjects is called attributable risk  This can also be understood as risk difference.  Attributable risk is mostly calculated in cohort studies,where individuals are assembled on exposure status and followed over a period of time.  Attributable risk gives more valid information to the health managers than the relative risk. This happens particularly when the disease is rare but occurs several times more frequently if a particular antecedent is present.  Attributable risk is better index of the public health importance of the risk factor in terms of the impact its reduction can make on the overall incidence of disease.  Calculation of AR = risk(incidence) in exposed – risk(incidence) in non- exposedwhich provides the risk difference
  • 6. ATTRIBUTABLE FRACTION (AF)  AF is the proportion of disease incidence that can be attributed to a specific exposure (among those who were exposed)  AR divided by incidence in the exposed X 100%